The Venture Codex Logo

The Venture Codex

3H Health Investment

Unit 616, 6/F, Core D, Cyberport 3, 100 Cyberport Road, Pokfulam, 999077, Hong Kong

Overview

Healthcare private equity fund focused on China.

Founded

2016

Deals ยท 12mo

1

Links

WebsiteLinkedIn

Stage focus

Series B
Series C

Geographic focus

China
United States

Sector focus

Health Care

Investment portfolio

8rounds
NAMEDATESIZE
Angitia Biopharmaceuticals
Feb 2026Participated
$130 MSeries D
Angitia Biopharmaceuticals
Dec 2024Participated
$120 MSeries C
Angitia Biopharmaceuticals
Oct 2023Participated
$46 MSeries B
Chamlion
Apr 2023Led
$34 MSeries B
EdiGene
Apr 2021Participated
$62 MSeries B
Microtech Medical
Dec 2020Participated
$88 MOther Equity
EdiGene
Oct 2020Led
$67 MSeries B
Imperative Care
Dec 2019Participated
$85 MSeries C
Angitia Biopharmaceuticals
Feb 2026Participated
$130 MSeries D
Angitia Biopharmaceuticals
Dec 2024Participated
$120 MSeries C
Angitia Biopharmaceuticals
Oct 2023Participated
$46 MSeries B
Chamlion
Apr 2023Led
$34 MSeries B
EdiGene
Apr 2021Participated
$62 MSeries B
Microtech Medical
Dec 2020Participated
$88 MOther Equity
EdiGene
Oct 2020Led
$67 MSeries B
Imperative Care
Dec 2019Participated
$85 MSeries C
8
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

3H Health Investment: 8 funding rounds are recorded in the selected participation categories.All available history.
3H Health Investment: 8 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B22
Series C+03
Other Equity01

Monthly Deal Activity

3H Health Investment: 8 deals are recorded across 83 months.All available history.
3H Health Investment: 8 deals are recorded across 83 months. All available history
MonthDeals
Dec '191
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '201
Nov '200
Dec '201
Jan '210
Feb '210
Mar '210
Apr '211
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '231
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '231
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '241
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '261
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

3H Health Investment: Health & Life Sciences is the largest displayed sector by deal count (8 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

3H Health Investment: Health & Life Sciences is the largest displayed sector by deal count (8 deals). All available history
SectorDeals
Health & Life Sciences8
Manufacturing2
AR/VR1

Deal Size Distribution

3H Health Investment: 8 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

3H Health Investment: 8 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M2
$50M-$100M4
$100M-$250M2
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

3H Health Investment: China has the largest recorded deal count among the displayed regions (7 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

3H Health Investment: China has the largest recorded deal count among the displayed regions (7 deals). All available history
RegionDeals
China7
United States1
3H Health Investment: 20 co-investors are shown, with Bain Capital Life Sciences sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

3H Health Investment: 20 co-investors are shown, with Bain Capital Life Sciences sharing 3 recorded deals. All available history
Co-investorShared deals
Bain Capital Life Sciences3
Elikon Venture3
IDG Capital3
Legend Capital3
Lilly Asia Ventures3
OrbiMed3
Hongshan Capital Group (Sequoia Capital China)2
Huagai Capital2
Janus Henderson Investors2
Kunlun Capital2
Yonghua Capital2
Ally Bridge Group1
Ascension Ventures1
Ascenta Capital1
Beijing Taikang Investment1
BlackRock1
BVF Partners1
China Everbright1
CICC Capital1
Delos Capital1

Investment Strategy

3H Health Investment: Led accounts for 25% and participating for 75% of round participation.All available history.
3H Health Investment: Led accounts for 25% and participating for 75% of round participation. All available history
CategoryDeals (count)Share (%)
Led225%
Participating675%
3H Health Investment: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
3H Health Investment: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead2100%
Co-led00%

Team

Minchuan Wang

Partner

Sheng Li

Founding Managing Partner